CD8A and ovarian neoplasm: We previously reported that therapeutic vaccination of established ID8DV ovarian tumors with uracil auxotrophs stimulated a significant increase in ovarian tumor antigen specific CD8+ T cells as well as total T cell populations that limited ovarian tumor development [16].